NCT04559581View on ClinicalTrials.gov

Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan

CompletedOBSERVATIONAL
Enrollment

425

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

December 18, 2024

Study Completion Date

January 22, 2025

Conditions
Lung Diseases, Interstitial
Interventions
DRUG

Nintedanib

Capsules

Trial Locations (1)

1416017

Nippon Boehringer Ingelheim Co., Ltd., Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY